GlassScriptPhysician profile
Naira Kocharian
NPI 1992816532
$5,581.55
in general payments reported to CMS, 2019-2025
46 companies · $1,185 in 2025
The $1,185 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $291 · 2020: $28.35 · 2021: $918 · 2022: $1,332 · 2023: $711 · 2024: $1,116 · 2025: $1,185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,942 · Education: $69.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,942.40 |
| Education | $69.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $943.12 | 2021-2025 | |
| Ucb, INC. | $618.02 | 2019-2025 | Briviact, Rystiggo, Zilbrysq |
| Lilly USA, LLC | $436.96 | 2019-2025 | Kisunla, Emgality, Reyvow |
| Teva Pharmaceuticals USA, INC. | $311.01 | 2021-2025 | Austedo Xr, Austedo Xr, Ajovy |
| Amneal Pharmaceuticals LLC | $249.26 | 2019-2025 | Rytary, Crexont |
| Neurelis, INC. | $237.14 | 2022-2025 | Valtoco |
| Argenx US, INC. | $216.09 | 2022-2024 | Vyvgart, Vyvgart Hytrulo |
| Biogen, INC. | $186.18 | 2019-2025 | Vumerity, Tysabri, Leqembi |
| Harmony Biosciences LLC | $182.06 | 2024-2025 | |
| Lundbeck LLC | $180.89 | 2021-2025 | Vyepti |
| Grifols USA, LLC | $164.73 | 2022-2025 | Gamunex-C |
| Amgen INC. | $156.22 | 2020-2022 | |
| Ge Healthcare | $130.75 | 2022-2025 | |
| Genzyme Corporation | $123.04 | 2019-2023 | |
| Sunovion Pharmaceuticals INC. | $122.68 | 2019-2022 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Naira Kocharian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.